Related Experiment Video

Updated: Aug 8, 2026

A Thin-skull Window Technique for Chronic Two-photon In vivo Imaging of Murine Microglia in Models of Neuroinflammation
12:07

A Thin-skull Window Technique for Chronic Two-photon In vivo Imaging of Murine Microglia in Models of Neuroinflammation

Published on: September 20, 2010

Does drug abuse influence the microglial response in AIDS and HIV encephalitis?

Juan-Carlos Arango1, Peter Simmonds, Ray P Brettle

  • 1School of Molecular and Clinical Medicine, Pathology (Neuropathology), University of Edinburgh, Edinburgh, Scotland, UK.

AIDS (London, England)
|April 13, 2004
PubMed
Abstract

Insights

Drug misuse may worsen microglial activation in HIV infection, potentially leading to long-term neurodegeneration in individuals with HIV/AIDS. Further research is needed to understand these complex interactions.

Area of Science:

  • Neuroimmunology
  • Neuropathology
  • Infectious Diseases

Background:

  • HIV infection can lead to neurological complications, including HIV encephalitis (HIVE).
  • Microglia, the brain's immune cells, play a crucial role in neuroinflammation.
  • The interaction between drug abuse and HIV-associated neuroinflammation is not fully understood.

Purpose of the Study:

  • To investigate the pathological evidence of microglial activation in the context of HIV infection and drug abuse.
  • To examine differences in microglial responses during early and late stages of HIV/AIDS.
  • To discuss the long-term consequences of microglial activation in chronic HIV infection, particularly concerning neurodegeneration.

Main Methods:

  • A brain pathology study comparing control patients, HIV-negative intravenous drug users, and HIV-positive drug users (presymptomatic and AIDS stages).
  • Inclusion of a non-drug-using AIDS patient group with HIV encephalitis (HIVE).
  • Identification and objective quantitation of microglia/macrophages using CD68 and MHCII antibodies in various brain regions.

Main Results:

  • AIDS patients exhibited significantly increased activated microglia/macrophages in both grey and white matter compared to non-AIDS patients.
  • HIV-positive drug users with HIVE showed a trend towards higher microglial activation than non-drug-using groups, though not consistently across all brain areas.
  • The study found significant microglial activation in all brain areas of AIDS patients with HIVE.

Conclusions:

  • Drug misuse may exacerbate HIV-induced microglial activation in certain individuals.
  • The extent of microglial activation is likely influenced by HIVE severity and systemic immune factors.
  • Long-term survival in HIV/AIDS patients with a history of drug use may be associated with premature neurodegeneration due to chronic microglial activation.

More Related Videos

A Rat Model of EcoHIV Brain Infection08:48

A Rat Model of EcoHIV Brain Infection

Published on: January 21, 2021

Identification of EcoHIV-Infected Cells in Microglia-Manipulated Transgenic Mice07:23

Identification of EcoHIV-Infected Cells in Microglia-Manipulated Transgenic Mice

Published on: December 20, 2024

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...